As one of the most popular and beloved scientific figures in the world, if Professor Neil deGrasse Tyson says that a particular scientific trend is great, most people tend to pay attention. That’s why his words of endorsement regarding driverless cars are having great for the industry.
Prof. Tyson expressed his support for self-driving cars and miracle cures via Tweet. He made a clear connection between the reduction of deaths caused by traffic accidents and the emergence of driverless technology.
When we cure all disease & stop aging, the leading cause of death will be Car Accidents, unless we develop Self-driving Cars.
— Neil deGrasse Tyson (@neiltyson) June 6, 2017
“When we cure all disease & stop aging, the leading cause of death will be Car Accidents, unless we develop Self-driving Cars,” the Tweet reads.
The Tweet hits on a few statistical facts that have long been on the minds of medical. With the myriad diseases, defects, and deterioration that humans suffer, frailty is certainly what kills the most number of humans in the world. Next to that is traffic accidents, which recent data shows is actually escalating to an alarming extent.
Supporters of self-driving cars and the makers of vehicles equipped with such capabilities have been insisting that removing human drivers from the equation would be considerably safer for everyone involved. Experts tend to agree with this sentiment, which is why various government agencies are trying to come up with a workable standard that allows for innovation within the tech industry.
On that note, if the proposal by a House Republican is approved, car makers working on self-driving technologies will be able to push for increased innovations. The proposal basically provides the US National Highway Safety Administration the power to decide on rules involving driverless vehicles, Reuters reports.
This would effectively neuter states from making their own rules regarding driverless tests on their roads. Although it has yet to pass, it’s expected to meet no significant obstruction given how much of the public’s attention is focused elsewhere.


FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Rewardy Wallet Integrates 1inch Swap API to Enable Gasless, Optimized Token Swaps
Samsung Set to Begin HBM4 Production for Nvidia and AMD
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



